Survivors For Solutions

We seek to preserve & protect the medical innovations that give people hope.

[Survivors For Solutions @Hopemattersmost]

The Survivors for Solutions 2025 Patient Policy Roadmap is now available!

Learn more about which policies patients support, like those that mitigate the negative impacts of the IRA to protect innovation, and which they oppose here:

https://t.co/KwC4GGZGVJ

[Survivors For Solutions @Hopemattersmost]

Most Favored Nation (MFN) pricing proposals would tie the U.S. drug market to other nations where the government sets the price. This will remove the incentives for research and development that are critical to driving innovation.

Learn more about why embracing socialist pricing systems will HURT patients in need: https://t.co/uGhxBbTERt

[Survivors For Solutions @Hopemattersmost]

NEW paper highlights how Most Favored Nation (MFN) pricing will hurt American innovation and, with it, patients in need.

A model of an MFN-style price-setting policy found it would have resulted in 167 to 342 fewer new approved drugs over an 18-year timeframe. Learn more about why MFN ultimately fails patients awaiting the next treatment or cure: https://t.co/HXYQiLfVrf

[Survivors For Solutions @Hopemattersmost]

Patients fighting chronic, rare, and life-threatening diseases depend on breakthrough treatments that require significant investment and take years to develop. Prescription drug price-setting policies undermine the incentives that drive this innovation. See a new op-ed in @dcexaminer highlighting how drug price controls impact patients: https://t.co/ryQSCgL1UJ

[Survivors For Solutions @Hopemattersmost]

IRA price-setting policies hurt American innovation. With investment down 68%, patients lose out on new medications that could be a cure for cancer or treatment for rare diseases. Read more about why drug price-setting policies are not the answer: https://t.co/BM1207USQw

[Survivors For Solutions @Hopemattersmost]

During today’s @GOPHELP/@HELPCmteDems markup, SFS urges lawmakers to OPPOSE S. 2658, the Medication Affordability and Patent Integrity Act.

Despite the bill’s name, the legislation would add unnecessary complications to our patent system, making it more difficult for innovators to take the risks necessary to develop life-changing treatments and cures.
https://t.co/VwEaCeqOJO

[Survivors For Solutions @Hopemattersmost]

.@CZ submitted comments to @CMSGov urging stronger prior auth reforms. 95% of requests are eventually approved, often making patients’ delays redundant and harmful. Read @CZ’s full comment here:
https://t.co/XhgXnOjEzG

[Survivors For Solutions @Hopemattersmost]

New SFS statements calls on Congress to prioritize strong IP protections to support America’s medical innovation ecosystem that delivers treatments and cures to patients in need. Read the full statement on the @HouseJudiciary/@JudiciaryGOP hearing here:

https://t.co/n9heZL5HmT

[Survivors For Solutions @Hopemattersmost]

Check out SFS’s latest statement on the recent House Judiciary IP Subcommittee hearing on improving access & innovation. Strong IP rights are essential to the creation of medical breakthroughs that improve and save patient lives. @HouseJudiciary @JudiciaryGOP

https://t.co/u5wjUCC6zO

[Survivors For Solutions @Hopemattersmost]

Survivors for Solutions urges lawmakers to reject Most Favored Nation (MFN) codification proposals.

By indexing U.S. prices to countries with single-payer healthcare systems, this price-setting policy will limit patient access to existing treatments and kill the development of future cures.

Learn more: https://t.co/Tds1OHWZt4

[Survivors For Solutions @Hopemattersmost]

SFS urges lawmakers to OPPOSE any efforts to codify Most Favored Nation (MFN) pricing.

Tying U.S. drug prices to countries that use discriminatory pricing metrics will effectively embrace valuation mechanisms that put disabled patients in the back of the line. Learn more: https://t.co/Tds1OHWZt4

[Survivors For Solutions @Hopemattersmost]

Patients living with chronic, rare, and life-threatening diseases rely on continued innovation that puts breakthrough treatments and cures within reach. SFS urges members of the House Judiciary IP Subcommittee to prioritize the intellectual property rights that allow innovators to take the risks needed to develop new medications. @JudiciaryGOP @HouseJudiciary

https://t.co/FJYvYaVVc8

[Survivors For Solutions @Hopemattersmost]

Strong IP rights are the foundation of America’s life-saving innovation pipeline. SFS urges lawmakers at tomorrow’s House Judiciary IP Subcommittee hearing on “Medicines and IP: Balancing Innovation and Access” to safeguard the patent protections that bring new treatments and cures to patients in need. @JudiciaryGOP @HouseJudiciary

https://t.co/FJYvYaVnmA

[Survivors For Solutions @Hopemattersmost]

Most Favored Nation (MFN) pricing would peg U.S. drug prices to foreign systems that routinely restrict and delay access to life-saving treatments and would undermine the incentives that drive pharmaceutical research and development. Read more about why experts warn that MFN would lead to 500 fewer new medicines in the next decade: https://t.co/7dcQoSk8gg

[Survivors For Solutions @Hopemattersmost]

MFN drug pricing would tie U.S. drug prices to foreign price-setting policies that limit access to treatments and cures. Embracing these systems at home will hurt American patient access to existing medications and slow the development of new medications for those in need. Read more on why MFN threatens American innovation and patient access:

https://t.co/7dcQoSk8gg

[Survivors For Solutions @Hopemattersmost]

SFS is calling on Congress to oppose MFN amendments. Socialist pricing mechanisms that deprioritize those in need have no place in American healthcare. Read the full statement here: https://t.co/UvnkhKP2k2

[Survivors For Solutions @Hopemattersmost]

Check out SFS’s new statement urging Congress to reject MFN codification proposals. Importing foreign price controls would devastate patient access and innovation. Read our statement here: https://t.co/UvnkhKP2k2

[Survivors For Solutions @Hopemattersmost]

Foreign pricing systems use tools like the quality-adjusted life year (QALY) that deprioritize care for older and disabled patients. Read more about how importing foreign pricing systems through Most Favored Nation (MFN) policies will impact America’s patients most in need:

https://t.co/ip5OU1S3Oj

[Survivors For Solutions @Hopemattersmost]

Patients deserve a healthcare system that prioritizes innovation, choice, and access to lifesaving care. Drug price-setting proposals like Most Favored Nation (MFN) do the opposite by tying American healthcare to foreign pricing systems that restrict access for patients struggling with cancer and chronic illness. Learn more about how price-setting policies harm patient access:

https://t.co/ip5OU1S3Oj

[Survivors For Solutions @Hopemattersmost]

New research shows that in the last 14 years, IP protections helped deliver 89 new treatments and save around 2.8 million lives by enabling innovators to invest in R&D and post-approval research. Price controls lower the value of IP, reducing incentives for this ongoing work that improves patient care.

Learn more: https://t.co/btQ1mKeq22

[Survivors For Solutions @Hopemattersmost]

Intellectual property rights drive continued healthcare R&D, including post-approval research expanding uses of existing medications. Price-setting policies like the IRA drug price "negotiations" and MFN risk undermining the system that fuels U.S. medical innovation by eliminating the exclusivity window that drives development.

Read more here:
https://t.co/btQ1mKeXRA